[Evaluation of an antituberculosis program in Ivory Coast. A study of the prospects of a short treatment (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care / Q000191:economics; D000995:Antitubercular Agents / Q000008:administration & dosage*; D002648:Child; D007560:Cote d'Ivoire; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010352:Patient Dropouts; D011515:Prothionamide / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D014376:Tuberculosis / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000191:economics
D000995:Antitubercular Agents; D011515:Prothionamide; D007538:Isoniazid; D013307:Streptomycin
Evaluation d'un programme de lutte antituberculeuse en Côte d'Ivoire. Etude des perspectives d'un traitement de courte durée.